Hydroxyzine Pamoate
27 NDCs across 8 manufacturers|27 Generic,0 Brand
Hydroxyzine Pamoate is used to treat anxiety disorders, nausea, pruritus, substance withdrawal syndrome and vomiting, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved before 1982, and the first generic was approved Jan 1, 1982. FDA's Orange Book lists 10 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $19 million on Hydroxyzine Pamoate across 1.6 million claims for 432,000 beneficiaries.
Hydroxyzine Pamoate is available as 27 NDCs from 8 manufacturers (27 generic, 0 brand), with NADAC prices from $0.06 to $0.44 per EA — the most expensive product costs about 7.1× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
27
27G / 0B
Manufacturers
8
competing in market
Price Spread
$0.06 – $0.44
per EA
7d Activity
avg -1.1% WoW · of 27 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
8 manufacturers producing HYDROXYZINE PAMOATE(2 pricing outliers)
Frequently Asked Questions
What is Hydroxyzine Pamoate used to treat?
Hydroxyzine Pamoate is used to treat anxiety disorders, nausea, pruritus, substance withdrawal syndrome and vomiting, per the National Library of Medicine's MED-RT classification.
When did Hydroxyzine Pamoate become available as a generic?
FDA approved the first generic Hydroxyzine Pamoate (ANDA) on Jan 1, 1982. The Orange Book currently lists 10 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Hydroxyzine Pamoate?
In 2024, Medicare Part D spent $19 million on Hydroxyzine Pamoate across 1.6 million claims for 432,000 beneficiaries.
How many Hydroxyzine Pamoate products are on the market?
The Hydroxyzine Pamoate drug market contains 27 NDCs from 8 manufacturers — 27 generic and 0 brand products.
What is the price range for Hydroxyzine Pamoate?
NADAC reference prices for Hydroxyzine Pamoate range from $0.0627 to $0.4446 per EA — the most expensive product costs about 7.1× the cheapest.
Which manufacturers make Hydroxyzine Pamoate?
8 manufacturers list Hydroxyzine Pamoate in NADAC. Ranked by number of NDCs, the largest are Sandoz Inc. (6), Teva Pharmaceuticals USA Inc. (5), Heritage Pharmaceuticals Inc. (4), Amneal Pharmaceuticals of New York LLC (4), American Health Packaging (3).
How has the price of Hydroxyzine Pamoate changed recently?
Over the past 7 days, 0 Hydroxyzine Pamoate NDCs rose and 25 fell, with a market-wide average change of -1.1%.